Stock PRTC PURETECH HEALTH PLC
Add to a list
To use this feature you must be a member
Log inSign up

News PureTech Health plc

Equities

PRTC

GB00BY2Z0H74

Delayed London S.E.
Other stock markets
 05:11:59 2024-04-23 am EDT 		5-day change 1st Jan Change
207 GBX +0.73% Intraday chart for PureTech Health plc -1.66% +6.59%
Apr. 16 EARNINGS AND TRADING: J Smart boosts revenue, Tertiary starts drilling AN
Apr. 16 PureTech Health plc Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary Fibrosis CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
PureTech Health plc - Notice of Results
AQ
PureTech Health: Notice of Results
BU
PureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 in Idiopathic Pulmonary Fibrosis
AQ
EARNINGS AND TRADING: J Smart boosts revenue, Tertiary starts drilling
AN
PureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary Fibrosis
BU
PureTech Health plc Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary Fibrosis
CI
US FDA hands fast track to PureTech head and neck cancer treatment
AN
PureTech Receives FDA Fast Track Designation for LYT-200 in Head and Neck Cancers
BU
PureTech Health plc Receives FDA Fast Track Designation for LYT-200 in Head and Neck Cancers
CI
Seaport Therapeutics Launches with $100 Million Oversubscribed Series a Financing Round to Advance Novel Neuropsychiatric Medicines
AQ
PureTech Health CEO Zohar moves to head-up portfolio firm Seaport
AN
PureTech Health Names Bharatt Chowrira Chief Executive; Receives $100 Million in Funding for Seaport Therapeutics Startup
MT
PureTech Health's Seaport Therapeutics Raises $100 Million at Launch
MT
PureTech Health CEO Steps Down; Successor Named
MT
PureTech Launches Seaport Therapeutics with $100 Million Oversubscribed Series A and Announces Management Transitions
BU
PureTech Health plc Announces Chief Executive Officer Changes
CI
PureTech Health plc Announces Management Changes
CI
Seaport Therapeutics announced that it has received $100 million in funding from Arch Venture Partners, L.P., Sofinnova Investment, Inc., Third Rock Ventures, LLC, PureTech Health plc
CI
ADRs End Flat, Ehang Holdings Ltd. Climbs 15.6%
DJ
European large-caps rise on eve of Fed decision
AN
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PRTC Stock
  4. News PureTech Health plc